Navigation Links
Covance Decides to Pursue Its Original Preclinical Strategy in China
Date:9/29/2008

PRINCETON, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced today that it will no longer pursue a 50-50 joint venture with WuXi Pharmatech to provide preclinical contract research services in China.

"We expect China will become an attractive region for outsourced drug development services over the longer-term. To seize this opportunity, we will pursue our original strategy to build our own world-class preclinical facility in the region and aggressively compete as the global market leader in a business we know very well. We plan to build a comprehensive preclinical capability that matches the high-quality facilities and scientific teams our clients have grown to trust in Europe and North America," said Joe Herring, Covance chairman and chief executive officer. "Once built, the preclinical facility will complement our existing Phase II/III clinical development, central laboratory and our new bioanalytical capability in China and allow us to enjoy the full financial benefits of further leveraging Covance's high- quality brand and drug development experience into Asia."

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 9,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about the nature, scope and timing and benefits of the planned joint venture as well as the attractiveness of China for delivering outsourced discovery and development services, the growth of the China market and advantages of conducting preclinical research and develo
'/>"/>

SOURCE Covance Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
2. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
3. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
4. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
5. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
6. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
7. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
8. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test
9. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
10. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
11. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
(Date:1/15/2014)... 2014 Cynvenio, a cancer diagnostics company ... genomic analysis of tumor cells in the bloodstream, today ... cancer decision support application powered by CollabRx, Inc. ... genomic test, Therapy Finder will provide breast cancer patients ...
(Date:1/15/2014)... 15, 2014 This webinar will focus ... clinical safety assessment in biosimilars. , Regulatory frameworks are ... drug development, however the complex nature of biopharmaceuticals makes ... and efficacy extremely challenging. Based on the specific aspects ...
(Date:1/15/2014)... VA (PRWEB) January 15, 2014 Two ... have continued their sponsorship of an annual competition for ... in, and access to, innovative STEM study. The competition ... TEAMS: Tests of Engineering Aptitude, Mathematics, and Sciences ...
Breaking Biology Technology:Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 2Cynvenio Offers New Breast Cancer Therapy Finder Application for its ClearID Breast Cancer Genomic Test 3Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... of peripheral vascular disease,announced today that it plans to ... 30, 2008, after the close of market on October ... teleconference at 2:00 p.m. PT,/ 5:00 p.m. ET on ...
... Cash On Hand and No Debt, NAPA, Calif., ... life sciences company engaged in the development,of technologies that ... company continues to maintain a strong, debt-free financial,position. Current ... Million,of which is invested in fully FDIC insured bank ...
... Die of Diabetes, BRUSSELS, October 13 The ... together key opinion,leaders to push for action to secure ... countries without access to care., The meeting, Access ... will be held on Saturday, October 25 in London, ...
Cached Biology Technology:VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29 2Senetek Affirms Strong Financial Position 2Senetek Affirms Strong Financial Position 3International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 2International Diabetes Federation Calls for Global Action to Keep All Children With Diabetes Alive 3
(Date:4/23/2014)... of dementia and affects some 400,000 people in Spain ... One of the reasons for this is the lack ... in nerve transmissions and the loss of memory in ... Institute of Neuroscience at the Universitat Autnoma de Barcelona ... and were able to develop a gene therapy which ...
(Date:4/23/2014)... is leading a 2 million Food Standards Agency (FSA) ... premises and industry workers. , Norovirus outbreaks can ... a batch of frozen strawberries infected 11,000 people in ... understanding of which strains cause infection and which foods ... , Researchers will produce data that will help ...
(Date:4/22/2014)... of Montana,s Wildlife Biology Program, co-wrote a research paper published ... of Sciences on how streamwater chemistry varies across a ... Lowe and co-authors from ... the Cary Institute of Ecosystem Studies, the University of Connecticut ... water samples collected every 10 meters along 32 tributaries of ...
Breaking Biology News(10 mins):Loss of memory in Alzheimer's mice models reversed through gene therapy 2New research focuses on streamwater chemistry, landscape variation 2
... , LAKE MARY, Fla. , April 26 Roundtable Concepts ... are of the highest quality components and specifications. A great review has been ... limited time only, is offering this promotional special: the RTC View 32" LCD ... at www.rtcview.com . , , ...
... 26 Kevin Harvick and the Shell-Pennzoil ... in a NASCAR Sprint Cup Series points-scoring race.  The Shell-Pennzoil ... Aaron,s 499 at Talladega Superspeedway where Harvick made a last-lap ... just 0.011 seconds to spare.  The finish was the eighth ...
... , April 26 Desarrolladora Homex,S.A.B. de C.V. ("Homex" or ... Quarter ended on March 31, 2010 (1). , ... As previously stated, effective ... Homex recognizes its revenues, costs and expenses when the,Company has transferred the ...
Cached Biology News:Roundtable Concepts Inc., the Company that has Officially Licensed Marvel Comic TVs and Officially Licensed Collegiate TVs, has just Launched their Own Line of HDTVs Named RTC View 2Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 2Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 3Harvick Breaks 115-Race Winless Streak To Take the Checkered Flag in Dramatic Finish at Talladega 4Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 2Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 3Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 4Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 5Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 6Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 7Homex Delivers Solid Q-1 2010 Revenue Growth of 12.2 Percent 8
Anti-Chicken IgY, (IgG) F(ab')2 Fragment Specific....
Presenilin 2 Immunogen: Synthetic peptide corresponding to residues 31-47 of human Presenilin 2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
Biology Products: